BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33685574)

  • 21. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
    Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
    Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral Testicular Germ Cell Tumors in the Era of Multimodal Therapy.
    Kopp RP; Chevinsky M; Bernstein M; Bosl G; Motzer R; Bajorin D; Feldman D; Carver BS; Sheinfeld J
    Urology; 2017 May; 103():154-160. PubMed ID: 27816603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significant calendar period deviations in testicular germ cell tumors indicate that postnatal exposures are etiologically relevant.
    Speaks C; McGlynn KA; Cook MB
    Cancer Causes Control; 2012 Oct; 23(10):1593-8. PubMed ID: 22941667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007.
    Trabert B; Chen J; Devesa SS; Bray F; McGlynn KA
    Andrology; 2015 Jan; 3(1):4-12. PubMed ID: 25331326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival differences by race/ethnicity among children and adolescents diagnosed with germ cell tumors.
    Williams LA; Frazier AL; Poynter JN
    Int J Cancer; 2020 May; 146(9):2433-2441. PubMed ID: 31304572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in incidence and survival of pediatric and adolescent patients with germ cell tumors in the United States, 1975 to 2006.
    Poynter JN; Amatruda JF; Ross JA
    Cancer; 2010 Oct; 116(20):4882-91. PubMed ID: 20597129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors.
    Wu Y; Meyers JP; Shi G; Jin Z; Xia J; Gu Y; Qian Q; Hong Y
    J Surg Oncol; 2019 Sep; 120(3):508-517. PubMed ID: 31140623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testicular cancer in Geneva, Switzerland, 1970-2012: incidence trends, survival and risk of second cancer.
    Schaffar R; Pant S; Bouchardy C; Schubert H; Rapiti E
    BMC Urol; 2019 Jul; 19(1):64. PubMed ID: 31291913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis.
    Mazzone E; Knipper S; Mistretta FA; Tian Z; Palumbo C; Soulieres D; De Cobelli O; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    World J Urol; 2020 Jun; 38(6):1535-1544. PubMed ID: 31463562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan.
    Suzuki S; Nagumo Y; Kandori S; Kojo K; Nitta S; Chihara I; Shiga M; Ikeda A; Kawahara T; Hoshi A; Negoro H; Bryan MJ; Okuyama A; Higashi T; Nishiyama H
    Int J Clin Oncol; 2024 Mar; 29(3):318-324. PubMed ID: 38265529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
    Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
    BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953-2015: A population-based prospective cohort study.
    Kvammen Ø; Myklebust TÅ; Solberg A; Møller B; Klepp OH; Fosså SD; Tandstad T
    PLoS One; 2019; 14(12):e0225942. PubMed ID: 31851716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contemporary Assessment of Long-Term Survival Rates in Patients With Stage I Nonseminoma Germ-Cell Tumor of the Testis: Population-Based Comparison Between Surveillance and Active Treatment After Initial Orchiectomy.
    Mazzone E; Mistretta FA; Knipper S; Tian Z; Palumbo C; Gandaglia G; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1153-e1162. PubMed ID: 31515197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site of extranodal metastasis impacts survival in patients with testicular germ cell tumors.
    Patel HD; Singla N; Ghandour RA; Freifeld Y; Cheaib JG; Woldu SL; Pierorazio PM; Bagrodia A
    Cancer; 2019 Nov; 125(22):3947-3952. PubMed ID: 31355922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical profile, treatment and survival outcome of testicular tumors: a pakistani perspective.
    Bhatti AB; Ahmed I; Ghauri RK; Saeed Q; Mir K
    Asian Pac J Cancer Prev; 2014; 15(1):277-80. PubMed ID: 24528039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overall survival analysis of adjuvant radiation versus observation in stage I testicular seminoma: a surveillance, epidemiology, and end results (SEER) analysis.
    Jones G; Arthurs B; Kaya H; Macdonald K; Qin R; Fairbanks RK; Lamoreaux WT; Jawed I; Tward JD; Martincic D; Shivnani AT; Lee CM
    Am J Clin Oncol; 2013 Oct; 36(5):500-4. PubMed ID: 22781383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in testicular germ cell tumours by ethnic group in the United States.
    Shah MN; Devesa SS; Zhu K; McGlynn KA
    Int J Androl; 2007 Aug; 30(4):206-13; discussion 213-4. PubMed ID: 17708751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.